213 related articles for article (PubMed ID: 24560255)
21. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
22. Common types of tuberculosis and co-infection with HIV at private health institutions in Ethiopia: a cross sectional study.
Alemie GA; Gebreselassie F
BMC Public Health; 2014 Apr; 14():319. PubMed ID: 24708793
[TBL] [Abstract][Full Text] [Related]
23. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and -uninfected adults at a teaching hospital, northwest Ethiopia.
Kassu A; Mengistu G; Ayele B; Diro E; Mekonnen F; Ketema D; Moges F; Mesfin T; Getachew A; Ergicho B; Elias D; Aseffa A; Wondmikun Y; Ota F
J Microbiol Immunol Infect; 2007 Apr; 40(2):116-22. PubMed ID: 17446959
[TBL] [Abstract][Full Text] [Related]
24. [Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].
Zimina VN; Kravchenko AV
Ter Arkh; 2015; 87(11):37-41. PubMed ID: 26821414
[TBL] [Abstract][Full Text] [Related]
25. HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB/HIV patients in Hawassa University Referral Hospital: a five year retrospective study.
Simieneh A; Hailemariam M; Amsalu A
Pan Afr Med J; 2017; 28():75. PubMed ID: 29255545
[TBL] [Abstract][Full Text] [Related]
26. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
Abdu M; Ali Y; Anteneh S; Yesuf M; Birhanu A; Mohamed S; Hussien A
PLoS One; 2021; 16(3):e0248490. PubMed ID: 33724992
[TBL] [Abstract][Full Text] [Related]
27. Integrated therapy for HIV and tuberculosis.
Manosuthi W; Wiboonchutikul S; Sungkanuparph S
AIDS Res Ther; 2016; 13():22. PubMed ID: 27182275
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of HIV-infected tuberculosis patients in Thailand.
Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
[TBL] [Abstract][Full Text] [Related]
29. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
[TBL] [Abstract][Full Text] [Related]
30. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
31. Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.
Jambo KC; Banda DH; Afran L; Kankwatira AM; Malamba RD; Allain TJ; Gordon SB; Heyderman RS; Russell DG; Mwandumba HC
Am J Respir Crit Care Med; 2014 Oct; 190(8):938-47. PubMed ID: 25225948
[TBL] [Abstract][Full Text] [Related]
32. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
33. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Tshitenge S; Ogunbanjo GA; Citeya A
Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of human immunodeficiency virus among pulmonary tuberculosis patients: A cross-sectional study.
Moglad EHO; Ahmed DAO; Awad Al-Kareem SMM; Elgoraish AG; Ali HTO; Altayb HN
Microbiol Immunol; 2020 Dec; 64(12):810-814. PubMed ID: 33090528
[TBL] [Abstract][Full Text] [Related]
35. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
[TBL] [Abstract][Full Text] [Related]
36. Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.
Koenig SP; Bernard D; Dévieux JG; Atwood S; McNairy ML; Severe P; Marcelin A; Julma P; Apollon A; Pape JW
PLoS One; 2016; 11(2):e0146903. PubMed ID: 26901795
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection.
Siddiqui S; Sarro Y; Diarra B; Diallo H; Guindo O; Dabitao D; Tall M; Hammond A; Kassambara H; Goita D; Dembele P; Traore B; Hengel R; Nason M; Warfield J; Washington J; Polis M; Diallo S; Dao S; Koita O; Lane HC; Catalfamo M; Tounkara A
Clin Immunol; 2015 Jul; 159(1):1-12. PubMed ID: 25889622
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV.
Thorman J; Björkman P; Marrone G; Tolera Balcha T; Tesfaye F; Abdissa T; Naniche D; Medstrand P; Reepalu A
Microbiol Spectr; 2021 Dec; 9(3):e0181021. PubMed ID: 34908450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
